1 / 34

Multimodality treatment of stage III NSCLC

This article by Jan P. van Meerbeeck discusses the importance of multimodality treatment in stage III non-small cell lung cancer, presenting insights and advancements in therapy. The author delves into the complexities and challenges of managing this stage of the disease, emphasizing the need for a comprehensive approach towards improving patient outcomes. Through an exploration of different treatment modalities and their integration, this piece sheds light on the evolving landscape of stage III NSCLC management.

dallon
Télécharger la présentation

Multimodality treatment of stage III NSCLC

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Multimodality treatment of stage III NSCLC Jan P van Meerbeeck EIS-Geneva March 31, 2007

More Related